---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-028683"
form_type: "8-K"
ticker: "TLPH"
cik: "0001427925"
company_name: "TALPHERA, INC."
filed_at: "2023-10-20T23:59:59+00:00"
generated_at: "2026-06-09T18:20:45.048916+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# AcelRx receives Nasdaq non-compliance notice for bid price below $1.00

## Summary
- Received Nasdaq notice on Oct 18, 2023 for failure to maintain minimum bid price of $1.00 for 30 consecutive business days.
- Must regain compliance by April 15, 2024; closing bid price must be at least $1.00 for ten consecutive business days.
- If not compliant, may qualify for additional 180-day period by meeting market value standards and intending a reverse stock split.
- Company will monitor closing bid price and evaluate available options to regain compliance.

## SEC filing metadata
- accession: 0001437749-23-028683
- form_type: 8-K
- ticker: TLPH
- cik: 0001427925
- company_name: TALPHERA, INC.
- filed_at: 2023-10-20T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1427925/000143774923028683/0001437749-23-028683-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1427925/000143774923028683/acrx20231019_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-028683
- JSON: https://secwatch.observer/filing/0001437749-23-028683.json
- Plain text: https://secwatch.observer/filing/0001437749-23-028683.txt

## Key facts
- Listing & Compliance Notices
  TALPHERA, INC. received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5450(a)(1)).
  - Exchange: nasdaq
  - Notice: noncompliance notice
  - Deficiency: minimum bid price
  - Rules: 5450(a)(1)
  source text: October 18, 2023, AcelRx Pharmaceuticals, Inc. (the “Company”) received written notice (the “Notice”) from the Nasdaq Stock Market, LLC (“Nasdaq”) notifying the Company that it is not in compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5450(a)(1) for continued listing on The Nasdaq Global Market. Nasdaq Listing Rule 5450(a)(1) requires listed securities to maintain a minimum bid price of $1.00 per share, and Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement exists if the deficiency continues for a period of 30 consecu
  evidence_url: https://www.sec.gov/Archives/edgar/data/1427925/000143774923028683/0001437749-23-028683-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.